In conclusion, our findings demonstrated that HOXA5 suppressed the activity of the Wnt/β-catenin pathway and transactivated TP53 simultaneously, thus inhibiting the cell cycle progression by downregulating cyclinD1 and upregulating p21, ultimately inhibiting the neoplasia and progression in cervical cancer. This evidence concerns the gene CDKN1A and cervical carcinoma.